Lakewood-Amedex Biotherapeutics Inc. Common Stock carries a market capitalization of 1.29M, placing it among publicly traded companies globally.
| Market Cap | 1.29M |
| Enterprise Value | N/A |
Lakewood-Amedex Biotherapeutics Inc. Common Stock's stock has declined approximately -96.82081% over the past 52 weeks. The 50-day moving average sits at 8.00, while the 200-day moving average is 8.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | -96.82081% |
| 50-Day Moving Average | 8.00 |
| 200-Day Moving Average | 8.00 |
| Average Volume (20 Days) | N/A |
Lakewood-Amedex Biotherapeutics Inc. Common Stock's most recent stock split took place on June 22, 2026 with a 10:1 split ratio.
| Last Split Date | 6/22/2026 |
| Split Ratio | 10:1 |